Clinical Trials Directory

Trials / Completed

CompletedNCT07074652

The Effect of SSRIs on Threat of Shock Potentiated Neural Circuitry

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
145 (actual)
Sponsor
UCLH/UCL Joint Research Office · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study aims to increase the knowledge about psychological processes which may contribute to mental health problems such as depression and anxiety. This study aims to investigate if administering Escitalopram, an antidepressant which increases serotonin levels in parts of the brain, affects how the brain processes emotional information. It is hoped that measuring these changes will increase the understanding of processes involved in mental health problems.

Conditions

Interventions

TypeNameDescription
DRUGEscitalopramParticipants received 2-3 weeks of escitalopram.
DRUGPlaceboParticipants received 2-3 weeks of placebo, matched in colour and size to the escitalopram.

Timeline

Start date
2017-12-01
Primary completion
2022-06-30
Completion
2022-06-30
First posted
2025-07-20
Last updated
2025-07-20

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT07074652. Inclusion in this directory is not an endorsement.

The Effect of SSRIs on Threat of Shock Potentiated Neural Circuitry (NCT07074652) · Clinical Trials Directory